在暴露前预防（PrEP）队列中，阿奇霉素/头孢曲松联合疗法治疗淋病导致大环内酯类药物的使用量超过耐药阈值达7倍之多。 - Suppr

Suppr

超能文献

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.

作者信息

Kenyon Chris

机构信息

HIV/STI Unit, Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium.

Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

J Infect Dis. 2021 Nov 16;224(9):1623-1624. doi: 10.1093/infdis/jiab178.

DOI:10.1093/infdis/jiab178

PMID:33822092

Abstract

摘要

相似文献

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.

J Infect Dis. 2021 Nov 16;224(9):1623-1624. doi: 10.1093/infdis/jiab178.

Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.

BMC Infect Dis. 2020 Nov 5;20(1):809. doi: 10.1186/s12879-020-05532-3.

Multidrug-resistant infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017.

Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00659.

Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.

Lancet Infect Dis. 2018 Jul;18(7):717-718. doi: 10.1016/S1473-3099(18)30340-2.

Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.

Lancet Infect Dis. 2019 Aug;19(8):833-842. doi: 10.1016/S1473-3099(19)30116-1. Epub 2019 Jun 10.

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.

BMC Infect Dis. 2018 Dec 3;18(1):609. doi: 10.1186/s12879-018-3528-4.

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Euro Surveill. 2017 Jan 5;22(1). doi: 10.2807/1560-7917.ES.2017.22.1.30431.

Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.

Methods Mol Biol. 2019;1997:37-58. doi: 10.1007/978-1-4939-9496-0_3.

Demographic and behavioural factors associated with antimicrobial susceptibility to azithromycin and ceftriaxone in .

Int J STD AIDS. 2021 Jan;32(1):67-74. doi: 10.1177/0956462420959171. Epub 2020 Nov 16.

CDC update on gonorrhea: expand treatment to limit resistance.

J Fam Pract. 2011 Dec;60(12):736-40.

引用本文的文献

Switching From Dual to Monotherapy for Gonorrhea is Associated With a Halving of Gonococcal Resistance to Azithromycin-A Modelling Study of MSM in Belgium.

Open Forum Infect Dis. 2025 Jun 2;12(6):ofaf320. doi: 10.1093/ofid/ofaf320. eCollection 2025 Jun.

Four recent insights suggest the need for more refined methods to assess the resistogenicity of doxycycline post exposure prophylaxis.

Curr Res Microb Sci. 2024 Apr 8;6:100234. doi: 10.1016/j.crmicr.2024.100234. eCollection 2024.

Lack of Association between Antimicrobial Consumption and Antimicrobial Resistance in a HIV Preexposure Prophylaxis Population: A Cross-Sectional Study.

Antibiotics (Basel). 2024 Feb 16;13(2):188. doi: 10.3390/antibiotics13020188.

Effect on the Resistome of Dual vs Monotherapy for the Treatment of : Results From a Randomized Controlled Trial (ResistAZM Trial).

Open Forum Infect Dis. 2023 Sep 8;10(10):ofad462. doi: 10.1093/ofid/ofad462. eCollection 2023 Oct.

Rethinking Screening Intensity in Terms of Reducing Prevalence or Increasing Selection Pressure for the Emergence of Resistant Gonorrhea: A Modeling Study of Men Who Have Sex With Men in Belgium.

Open Forum Infect Dis. 2023 Mar 27;10(4):ofad165. doi: 10.1093/ofid/ofad165. eCollection 2023 Apr.

Identification of Emerging Multidrug-Resistant Isolates against Five Major Antimicrobial Agent Options.

Med Sci (Basel). 2023 Mar 31;11(2):28. doi: 10.3390/medsci11020028.

Tolerance to Ceftriaxone in : Rapid Induction in WHO P Reference Strain and Detection in Clinical Isolates.

Antibiotics (Basel). 2022 Oct 26;11(11):1480. doi: 10.3390/antibiotics11111480.

Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.

Sex Transm Infect. 2023 May;99(3):149-155. doi: 10.1136/sextrans-2022-055439. Epub 2022 May 18.

Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.

Sci Rep. 2021 Nov 4;11(1):21659. doi: 10.1038/s41598-021-00675-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.

作者信息

Kenyon Chris

机构信息

HIV/STI Unit, Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium.

Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

J Infect Dis. 2021 Nov 16;224(9):1623-1624. doi: 10.1093/infdis/jiab178.

DOI:10.1093/infdis/jiab178

PMID:33822092

Abstract

摘要